Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Qualigen Therapeutics Inc
QLGNCurrent price
4.77 USD
+0.27 USD (+6.00%)
Last closed
4.53 USD
Company
www.qualigeninc.com
ISIN
US74754R1032
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 697 557 USD
Yield for 12 month
-85.76 %
1Y
3Y
5Y
10Y
15Y
QLGN
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. Address: 5857 Owens Avenue, Carlsbad, CA, United States, 92008
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+4 983 556 USD
Current Quarter
–
Last Quarter
–
Current Year
-4 495 USD
Last Year
+680 801 USD
Current Quarter
-754 287 USD
Last Quarter
-364 385 USD
Key Figures QLGN
1 year
3 years
5 years
10 years
EBITDA
-8 334 197 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-75.07 %
PEG Ratio
–
Return On Equity TTM
-841.66 %
Wall Street Target Price
5 USD
Revenue TTM
4 983 556 USD
Book Value
-0.45 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
13.7 %
Dividend Yield
–
Gross Profit TTM
680 801 USD
Earnings per share
-1.64 USD
Diluted Eps TTM
-1.64 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics QLGN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History QLGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
05.11.2024
Dividend Date
26.05.2020
Stock Valuation QLGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.6849
Price Sales TTM
0.369
Enterprise Value EBITDA
-0.0544
Price Book MRQ
0.4055
Financials QLGN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators QLGN
For 52 weeks
0.075 USD
5.31 USD
50 Day MA
0.16 USD
Shares Short Prior Month
108 951
200 Day MA
0.28 USD
Short Ratio
0.72
Shares Short
110 185
Short Percent
0.4 %
BeatStart